These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34835268)

  • 1. Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in
    Mamedov T; Yuksel D; Ilgın M; Gürbüzaslan I; Gulec B; Mammadova G; Ozdarendeli A; Yetiskin H; Kaplan B; Islam Pavel ST; Uygut MA; Hasanova G
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice.
    Mamedov T; Yuksel D; Ilgın M; Gurbuzaslan I; Gulec B; Yetiskin H; Uygut MA; Islam Pavel ST; Ozdarendeli A; Mammadova G; Say D; Hasanova G
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants.
    Mamedov T; Yuksel D; Gurbuzaslan I; Ilgin M; Gulec B; Mammadova G; Ozdarendeli A; Pavel STI; Yetiskin H; Kaplan B; Uygut MA; Hasanova G
    Front Plant Sci; 2023; 14():1202570. PubMed ID: 37600182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor binding domain proteins of SARS-CoV-2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern.
    Khorattanakulchai N; Manopwisedjaroen S; Rattanapisit K; Panapitakkul C; Kemthong T; Suttisan N; Srisutthisamphan K; Malaivijitnond S; Thitithanyanont A; Jongkaewwattana A; Shanmugaraj B; Phoolcharoen W
    J Med Virol; 2022 Sep; 94(9):4265-4276. PubMed ID: 35615895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates.
    Siriwattananon K; Manopwisedjaroen S; Shanmugaraj B; Rattanapisit K; Phumiamorn S; Sapsutthipas S; Trisiriwanich S; Prompetchara E; Ketloy C; Buranapraditkun S; Wijagkanalan W; Tharakhet K; Kaewpang P; Leetanasaksakul K; Kemthong T; Suttisan N; Malaivijitnond S; Ruxrungtham K; Thitithanyanont A; Phoolcharoen W
    Front Plant Sci; 2021; 12():682953. PubMed ID: 34054909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient production of receptor-binding domain of SARS-CoV-2 in Nicotiana benthamiana plants induces specific antibodies in immunized mice.
    Ceballo Y; López A; González CE; Ramos O; Andújar I; Martínez RU; Hernández A
    Mol Biol Rep; 2022 Jul; 49(7):6113-6123. PubMed ID: 35526244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant-Expressed Receptor Binding Domain of the SARS-CoV-2 Spike Protein Elicits Humoral Immunity in Mice.
    Maharjan PM; Cheon J; Jung J; Kim H; Lee J; Song M; Jeong GU; Kwon Y; Shim B; Choe S
    Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana.
    Rattanapisit K; Shanmugaraj B; Manopwisedjaroen S; Purwono PB; Siriwattananon K; Khorattanakulchai N; Hanittinan O; Boonyayothin W; Thitithanyanont A; Smith DR; Phoolcharoen W
    Sci Rep; 2020 Oct; 10(1):17698. PubMed ID: 33077899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice.
    Phatarphekar A; Vidyadhar Reddy GEC; Gokhale A; Karanam G; Kuchroo P; Shinde K; Masand G; Pagare S; Khadpe N; Pai SS; Vijayan V; Ramnath RL; Pratap Reddy K; Rao P; Harinarayana Rao S; Ramana V
    Vaccine; 2022 Jul; 40(32):4522-4530. PubMed ID: 35718590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Human Angiotensin- Converting Enzyme 2 as a Potential Therapeutic Tool for COVID-19 is Produced at High Levels In
    Mamedov T; Gurbuzaslan I; Yuksel D; Ilgin M; Mammadova G; Ozkul A; Hasanova G
    Front Plant Sci; 2021; 12():742875. PubMed ID: 34938305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Transient Expression of Receptor-Binding Domain of SARS-CoV-2 and the Conserved M2e Peptide of Influenza A Virus Linked to Flagellin in
    Mardanova ES; Kotlyarov RY; Ravin NV
    Plants (Basel); 2022 Dec; 11(24):. PubMed ID: 36559537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody cocktail effective against variants of SARS-CoV-2.
    Liang KH; Chiang PY; Ko SH; Chou YC; Lu RM; Lin HT; Chen WY; Lin YL; Tao MH; Jan JT; Wu HC
    J Biomed Sci; 2021 Nov; 28(1):80. PubMed ID: 34814920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies.
    Rattanapisit K; Bulaon CJI; Khorattanakulchai N; Shanmugaraj B; Wangkanont K; Phoolcharoen W
    PLoS One; 2021; 16(8):e0253574. PubMed ID: 34379620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response.
    Liu Z; Xu W; Xia S; Gu C; Wang X; Wang Q; Zhou J; Wu Y; Cai X; Qu D; Ying T; Xie Y; Lu L; Yuan Z; Jiang S
    Signal Transduct Target Ther; 2020 Nov; 5(1):282. PubMed ID: 33247109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants.
    Mamedov T; Yuksel D; Gurbuzaslan I; Gulec B; Mammadova G; Ozdarendeli A; Pavel STI; Yetiskin H; Kaplan B; Uygut MA; Hasanova G
    Front Plant Sci; 2023; 14():1290042. PubMed ID: 38034565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant.
    Phoolcharoen W; Shanmugaraj B; Khorattanakulchai N; Sunyakumthorn P; Pichyangkul S; Taepavarapruk P; Praserthsee W; Malaivijitnond S; Manopwisedjaroen S; Thitithanyanont A; Srisutthisamphan K; Jongkaewwattana A; Tomai M; Fox CB; Taychakhoonavudh S
    Vaccine; 2023 Apr; 41(17):2781-2792. PubMed ID: 36963999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent neutralizing RBD-specific antibody cocktail against SARS-CoV-2 and its mutant.
    Jia L; Liu YP; Tian LF; Xiong C; Xu X; Qu H; Xiong W; Zhou D; Wang F; Liu Z; Yan XX; Xu W; Tang L
    MedComm (2020); 2021 Sep; 2(3):442-452. PubMed ID: 34541573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.